Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
China Journal of Chinese Materia Medica ; (24): 2606-2612, 2023.
Article in Chinese | WPRIM | ID: wpr-981363

ABSTRACT

Xiao Chaihu Decoction combined with Maxing Shigan Decoction is a classic herbal formula. All of them are derived from Treatise on Cold Damage(Shang Han Lun) by ZHANG Zhong-jing. This combination has the effects of harmonizing lesser yang, relieving exterior syndrome, clearing lung heat, and relieving panting. It is mainly used for treating the disease involving the triple-Yang combination of diseases and accumulation of pathogenic heat in the lung. Xiao Chaihu Decoction combined with Maxing Shigan Decoction is a classic combination for the treatment of exogenous diseases involving the triple-Yang combination. They are commonly used in exogenous diseases, especially in the north of China. This combination is also the main treatment strategy for coronavirus disease 2019(COVID-19) accompanied by fever and cough. Maxing Shigan Decoction is a classical herbal formula for treating the syndrome of phlegm-heat obstructing the lung. "Dyspnea after sweating" suggests the accumulation of pathogenic heat in the lung. Patients with mild symptoms may develop cough and asthma along with forehead sweating, and those in critical severe may develop whole-body sweating, especially the front chest. Modern medicine believes that the above situation is related to lung infection. "Mild fever" refers to syndromes rather than pathogenesis. It does not mean that the heat syndrome is not heavy, instead, it suggests that severe heat and inflammation have occurred. The indications of Xiao Chaihu Decoction combined with Maxing Shigan Decoction are as follows.(1) In terms of diseases, it is suitable for the treatment of viral pneumonia, bronchopneumonia, lobar pneumonia, mycoplasma pneumonia, COVID-19 infection, measles with pneumonia, severe acute respiratory syndrome(SARS), avian influenza, H1N1 influenza, chronic obstructive pulmonary disease with acute exacerbation, pertussis, and other influenza and pneumonia.(2) In terms of syndromes, it can be used for the syndromes of bitter mouth, dry pharynx, vertigo, loss of appetite, vexation, vomiting, and fullness and discomfort in the chest and hypochondrium. It can also be used to treat alternate attacks of chill and fever and different degrees of fever, as well as chest tightness, cough, asthma, expectoration, dry mouth, wanting cold drinks, feeling agitated, sweating, yellow urine, dry stool, red tongue, yellow or white fur, and floating, smooth, and powerful pulse, especially the right wrist pulse.


Subject(s)
Animals , Humans , Cough , Syndrome , Influenza A Virus, H1N1 Subtype , Influenza, Human , COVID-19 , Drugs, Chinese Herbal/pharmacology , Lung , Pulmonary Disease, Chronic Obstructive/drug therapy , Asthma , Critical Care , Medicine, Chinese Traditional
2.
China Journal of Chinese Materia Medica ; (24): 1268-1275, 2021.
Article in Chinese | WPRIM | ID: wpr-879029

ABSTRACT

To systemically evaluate the efficacy and safety of Maxing Shigan Decoction in the treatment of community acquired pneumonia(CAP) and provide a reference for the treatment of CAP. Databases of CNKI, Wanfang, VIP, SinoMed, EMbase, Cochrane Library, Web of Science and PubMed were searched(from inception to May 30, 2020) to screen the randomized controlled trials(RCTs) of Maxing Shigan Decoction in treating CAP. Two authors independently screened and selected relevant literature and extracted data based on the inclusion and exclusion criteria. Any disagreement or differences was resolved through discussion. The bias risk assessment tool recommended by Cochrane handbook was used to evaluate the quality of the included studies, and RevMan 5.3 software was used for data analysis. Seventeen RCTs were finally included, involving 1 309 patients. Meta-analysis showed that Maxing Shigan Decoction combined with conventional Western medicine treatment could improve clinical efficacy in patients with CAP more effectively as compared with conventional Western medicine treatment alone, mainly in terms of anti-inflammatory effects, a decrease in C-reactive protein(CRP) content(MD=-6.01, 95%CI[-10.95,-1.06], P=0.02)and white blood cell(WBC) count, a decrease in procalcitonin(PCT) level(MD=-0.74, 95%CI[-0.77,-0.71], P<0.000 1), and shortened recovery time of cough and fever. Maxing Shigan Decoction has certain curative effect on CAP, but there are problems in the methodology of included studies. High-quality stu-dies are still needed for further verification.


Subject(s)
Humans , Community-Acquired Infections/drug therapy , Cough , Drugs, Chinese Herbal , Pneumonia/drug therapy , Randomized Controlled Trials as Topic , Treatment Outcome
3.
Chinese Pharmacological Bulletin ; (12): 878-883, 2019.
Article in Chinese | WPRIM | ID: wpr-857243

ABSTRACT

Aim: To study the effect of influenza A virus on autophagy in lung macrophages and the intervention effect of Maxing Shigan decoction. Methods: Influenza A virus infected RAW264. 7 cells as the research object, the experiment set up Maxing Shigan decoction containing serum low, medium and high doses groups, oseltamivir group, 3-MA + influenza virus group, influenza virus group, 3-MA group, rapamycin group and control group. After 12 hours of intervention, the treated cells were examined as follows; (1) the autophagy of each group was detected by laser confocal microscopy; (2) the autophagy and distribution of virus particles were detected by transmission electron microscopy; (3) the expressions of autophagy marker proteins LC3-1 and LC3-II were detected by Western blot. Results: The serum containing Maxing Shigan decoction could inhibit the membrane aggregation of autophagy marker protein LC3 induced by influenza virus in varying degrees, the increase of autophagosome and autophagy lysosome induced by influenza virus, the expression of LC3-II and the ratio of LC3-U to LC3-1 to some extent, and showed a dose-effect relationship (positive correlation). Conclusion Maxing Shigan decoction may regulate the pathogenesis of influenza A virus by inhibiting autophagy induced by influenza A virus.

4.
Chinese Journal of Pathophysiology ; (12): 353-359, 2019.
Article in Chinese | WPRIM | ID: wpr-744251

ABSTRACT

AIM:To investigate the effects of Maxing-Shigan decoction on airway remodeling and expression of matrix metalloproteinase-9 (MMP-9) and tissue inhibitor of metalloproteinase-1 (TIMP-1) in the lung tissues of asthmatic mice, and to explore its possible mechanism in treatment of asthma.METHODS:The BALB/c mice were divided into blank control group, model group, low-dose Maxing-Shigan decoction group, middle-dose Maxing-Shigan decoction group, high-dose Maxing-Shigan decoction group and positive control group.The mice were sensitized and challenged with ovalbumin to establish asthma model.The mice in blank control group and model group were given saline by oral administration before 30 min of suscitation.The mice in low-dose, middle-dose and high-dose Maxing-Shigan decoction groups were given Maxing-Shigan decoction at 5.0 g/kg, 10.0 g/kg and 20.0 g/kg, respectively, by oral administration before 30 min of suscitation.The mice in positive control group was given dexamethasone at 0.005 g/kg by oral administration before 30 min of suscitation.After consecutive administration for 7 d, the variations of airway responsiveness, the percentage of the goblet cells, the collagen deposition, and the eosinophil (EOS) counts in bronchoalveolar lavage fluid (BALF) of each group were observed.The protein levels of MMP-9 and TIMP-1 in the lung tissues were determined by ELISA and Western blot.The mRNA expression of MMP-9 and TIMP-1 was detected by RT-qPCR.RESULTS:Compared with blank control group, the airway responsiveness, the goblet cell percentage, the collagen deposition, the EOS counts in BALF, the protein levels of MMP-9 and TIMP-1, and the mRNA expression of MMP-9 and TIMP-1 were significantly increased in model group (P<0.01).Compared with model group, all of the indexes were reversed in low-dose, middle-dose and high-dose Maxing-Shigan decoction groups and positive control group (P<0.05 or P<0.01).CONCLUSION:Maxing-Shigan decoction improves airway remodeling in asthma model mice by down-regulating the expression of MMP-9 and TIMP-1.

5.
Chinese Traditional and Herbal Drugs ; (24): 1591-1596, 2017.
Article in Chinese | WPRIM | ID: wpr-852846

ABSTRACT

Objective: To explore the effect of TLR4 on type A influenza virus induced lung tissue injury, and to further explore the intervention effect of Maxing Shigan Decoction (MXSGD). Methods: The WT influenza virus model in mice infected with influenza A virus was established. The mice were devided into low, medium, and high dose MXSGD groups, oseltamivir group, IAV group, and Sham group. After 7 d, the treated animals were treated with corresponding clinical equivalent dose of drug. Detection in mouse body weight, lung index, spleen index, thymus index, pathological changes of lung, and ELISA method for the detection of alveolar irrigation lotion in inflammatory cytokines (TNF-α, IL-1β, and IL-6) content, real-time PCR and Western blotting detection of lung tissue TLR4, MyD88, TRAF6 mRNA, and protein expression. Results: MXSGD could up-regulate the weight, spleen index, and thymus index of type A influenza virus infection in WT mice, improve the pathological injury of lung tissue, decrease alveolar lavage lotion proinflammatory cytokines content, and down regulate the expression of MyD88 and TRAF6 mRNA and protein in lung index and lung tissue and there is a certain dose effect relationship. The effect of high dose MXSGD group was close to oseltamivir. Conclusion: MXSGD as effective anti influenza virus of traditional Chinese medicine compound can effectively reduce lung inflammation, protect immune organs, and regulate cytokine balance. The possible mechanism is alleviating the lung injury caused by type A influenza virus infection in mice through inhibition TLR4-MyD88-TRAF6 signaling pathway of activation.

6.
Journal of Zhejiang Chinese Medical University ; (6): 719-721, 2015.
Article in Chinese | WPRIM | ID: wpr-482015

ABSTRACT

Objective]To clarify the meaning of the phase“without high fever”in ShangHan Lun. [Method]To sort out the explanation of “without high fever”of interpreters from past to nowadays,then to analyse the scriptures of ShangHanLun and Sypnosis of Golden Chamber that involve“without high fever”,to re-define the exact meaning of the phase. [Result] Two main opinions are found about the explanation of“without high fever”in the past literature:one is “heat is in interior not exterior”,while the other is“exterior syndrome is passed”,Both are not accorded with Zhong Jing’s word expression and the real clinical situation. If “high fever”is explained as“the fever characteristics of Yang-ming disease”,the scripture involved and the meaning of“without high fever”can be thoroughly understood.[Conclusion] “Without high fever”is the phase Zhang-zhong-jing used to differentiate the disease in scripture from Yang-ming visceral substantial syndrome .Clarifying the phase“without high fever”helps us to better understand the meaning of related scriptures.

7.
Chinese Herbal Medicines ; (4): 211-215, 2010.
Article in Chinese | WPRIM | ID: wpr-499826

ABSTRACT

Objective To establish an objective method for evaluating the intrinsic characteristics between cold and hot nature of Chinese materia medica(CMM)through the different effects of Mahuang decoction(MHD)and Maxing Shigan decoction(MSD)on animal temperature tropism.Methods The equipment with cold/hot pads was used to investigate the variety ofthe temperature tropism between two groups of mice treated by MHD and MSD,respectively.Meanwhile,the activities ofadenosine triphosphatase(ATPase),superoxide dismutase,succinate dehydrogenase,and malondialdehyde were measured.Results After treated by MHD,the macroscopic behavioral index of remaining rate on warm pad(40 ℃)of mice decreasedsignificantly(P < 0.05),suggesting the enhancement of cold tropism,meanwhile,the internal indices of ATPase activity and oxygen consuming volume increased significantly(P < 0.05),suggesting the enhancement of energy metabolism.On theother hand,the above-mentioned indices in MSD group changed on the inverse way.Conclusion The relative drug natureof MHD and MSD revealed in this study is consistent with the theoretical prognostication or definition.It indicates that theinternal cold and hot nature of CMM could be reflected in ethological way on the changes of animal temperature tropismwhich might be internally regulated by body energy metabolism.

8.
Chinese Traditional Patent Medicine ; (12)1992.
Article in Chinese | WPRIM | ID: wpr-578856

ABSTRACT

AIM:To investigate the mechanism of Maxing Shigan Decoction(Herba ephedrae,Semen armeniacae amarum,Radix er Rhizoma glycyrrhizae,Gypsum fibrosum) against type Ⅰ hypersenstivity reaction. METHODS: The experiment of passive cutaneous anaphylaxis(PCA) was used to determine the effect of Maxing Shigan Decoction on degranulation of mast cells in vivo.For in vitro study,the drug serum of Maxing Shigan Decoction was added to the culture medium of sensitized RBL-2H3 cells.The antigen-induced release of degranulation was measured by enzymatic assay,histamine by enzyme immunoassay(EIA) and cytokines by enzyme-linked immunosorbent assay(ELISA). RESULTS: The results showed that treatment with drug serum of Maxing Shigan Decoction was followed by a decrease in PCA of rats and in degranulation,histamine,TNF-? and IL-4 from RBL-2H3 cells induced by antigen. CONCLUSION: Maxing Shigan Decoction may suppress the type Ⅰ hypersensitivity reaction by inhibiting the action of mast cells.

SELECTION OF CITATIONS
SEARCH DETAIL